Shinpoong Pharmaceutical Co.,Ltd (KRX:019175)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,350
-50 (-0.30%)
Last updated: Mar 20, 2026, 9:30 AM KST
Market Cap562.32B +17.8%
Revenue (ttm)231.90B +7.6%
Net Income-3.71B
EPS-74.01
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume5,198
Open16,350
Previous Close16,400
Day's Range16,350 - 16,350
52-Week Range9,650 - 55,000
Beta1.30
RSI36.72
Earnings DateMar 20, 2026

About KRX:019175

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; woun... [Read more]

Sector Healthcare
Founded 1962
Employees 809
Stock Exchange Korea Stock Exchange
Ticker Symbol 019175
Full Company Profile

Financial Performance

In 2024, KRX:019175's revenue was 221.09 billion, an increase of 10.42% compared to the previous year's 200.23 billion. Losses were -14.82 billion, -74.15% less than in 2023.

Financial Statements